Faktor-faktor yang Mempengaruhi Ketaatan Terapi pada Orang dengan Skizofrenia: Sebuah Systematic Review

Authors

  • Ice Yulia Wardani Fakultas Ilmu Keperawatan, Universitas Indonesia
  • Achir Yani S. Hamid Fakultas Ilmu Keperawatan, Universitas Indonesia
  • Budi Anna Keliat Fakultas Ilmu Keperawatan, Universitas Indonesia

DOI:

https://doi.org/10.32583/keperawatan.v16i3.2039

Keywords:

ketaatan, program terapi, skizofrenia

Abstract

Skizofrenia merupakan jenis gangguan jiwa terbesar dialami orang dengan gangguan jiwa. Ketaatan terhadap terapi merupakan tantangan terbesar dalam penatalaksanaan skizofrenia. Penyebab ketaatan bersifat multifaktor. Sistematik review ini bertujuan untuk mendapatkan bukti empiris faktor yang memengaruhi ketaatan terhadap terapi pada orang dengan Skizofrenia. Penelusuran diawali dengan mengidentifikasi data pada database Pubmed,  Embase, ClinicalKey , Proquest  Scopus, dan Medline dengan menggunakan beberapa kata kunci seperti ‘Schizophrenia patients’ ‘person with schizophrenia’ ‘Contributing factors’ ‘reasons’ ‘Causes’ ‘influencing factors’ schizophrenia’ ‘Contributing factors’ ‘reasons’ ‘Causes’ ‘influencing factors’ ‘Adherence’ ‘compliance’ ‘nonadherence’ ‘noncompliance’ ‘treatment adherence’ dan ‘Treatment compliance’ dan ditemukan sejumlah 4290 artikel dari tahun 2012-2022. Setelah dilakukan skrening berdasarkan kriteria inkulusi, terdapat 6 artikel yang dianalsis dalam sistematic review ini yang sebelumnya sudah ditelaah dengan menggunakan Critical Appraisals Skills Programme. Hasil systematic review ini menunjukkan bahwa setidaknya terdapat 4 faktor yang mempengaruhi ketaatan, yaitu: faktor sosiodemografik, faktor individual/internal, faktor eksternal, dan faktor terapi.

References

Bernardo, M., Amoretti, S., Cuesta, M. J., Parellada, M., Mezquida, G., Gonzáles-Pinto, A., . . . Micó, J. A. (2020). The prevention of relapses in first episodes of schizophrenia: The 2EPs Project, background, rationale and study design. Revista de Psiquiatría y Salud Menta.

El-Missiry, A., Elbatrawy, A., El Missiry, M., Moneim, D. A., Ali, R., & Essawy, H. (2015). Comparing cognitive functions in medication adherent and non-adherent patients with schizophrenia. J. Psychiatr. Res., 70, 106-112.

Endriyani, L., Chien, C. H., Huang, X. Y., & Chieh-Yu, L. (2019). The influence of adherence to antipsychotics medication on the quality of life among patients with schizophrenia in Indonesia. Perspectives in psychiatric care, 55(2), 147–152.

Eticha, T., Teklu, A., Ali, D., Solomon, G., & Alemayehu, A. (2015). Factors Associated with Medication Adherence among Patients with Schizophrenia in Mekelle, Northern Ethiopia. PLOS ONE, 10(3), e0120560.

Hasan, A. A. (2019). Factors that leading to the schizophrenic patient to leave psychotherapy. Indian J. Forensic Med. Toxicol., 13(4), 1194-1198.

Idaiani, S., Yunita, I., Tjandrarini, D., Indrawati, L., Darmayanti, I., Kusumawardani, N., & Mubasyiroh, R. (2019). Prevalensi Psikosis di Indonesia berdasarkan Riset Kesehatan Dasar 2018. Jurnal Penelitian Dan Pengembangan Pelayanan Kesehatan, 3(1), 9-16. https://doi.org/10.22435/jpppk.v3i1.1882

Kim, J., Ozzoude, M., Nakajima, S., Shah, P., Caravaggio, F., Iwata, Y., De Luca, V., Graff-Guerrero, A., & Gerretsen, P. (2020). Insight and medication adherence in schizophrenia: An analysis of the CATIE trial. Neuropharmacology, 168, 107634.

Moges, S., Belete, T., Mekonen, T., & Menberu, M. (2021). Lifetime relapse and its associated factors among people with schizophrenia spectrum disorders who are on follow up at Comprehensive Specialized Hospitals in Amhara region, Ethiopia: a cross-sectional study. International journal of mental health systems, 15(1), 42. https://doi.org/10.1186/s13033-021-00464-0

Novick, D., Montgomery, W., Treuer, T., Aguado, J., Kraemer, S., & Haro, J. M. (2015). Relationship of insight with medication adherence and the impact on outcomes in patients with schizophrenia and bipolar disorder: Results from a 1-year European outpatient observational study. BMC Psychiatry, 15.

Rabinovitch, M., Cassidy, C., Schmitz, N., Joober, R., & Malla, A. (2013). The influence of perceived social support on medication adherence in first-episode psychosis. Canadian journal of psychiatry. Revue canadienne de psychiatrie, 58(1), 59–65.

Saba, N.U., Z., Muraraiah, S., & Chandrashekar, H. (2019). Medication adherence in schizophrenia: Understanding patient’s views. Natl. J. Physiol. Pharm. Pharmacol., 9(5), 373-378

Shah, C., Patel, K., Amin, N., & Shah, C. (2019). Study of various factors affecting compliance in schizophrenia: A single center experience in India. Arch. Psychiatry Psychother., 21(3), 41-52

Sitawati, L., Wuryaningsih, C. E., & Anshari, D. (2019). Akses Pelayanan Rumah Sakit Menjadi Faktor Dominan Kepatuhan Minum Obat pada Penderita Skizofrenia. Jurnal Kesehatan Metro Sai Wawai, 22(1).

Stuart, Keliat, & Pasaribu. (2016). Prinsip dan Praktik Keperawatan Kesehatan Jiwa Stuart: Indonesia 1st edition. Elsevier.

Sukrang, Fauzan, Hasnidar, M Khariyah, & MA Munir. (2022). The Relationship Between Medication Compliance And Relapse In Schizophrenia Patients. Comprehensive Health Care, 6(3), 117-124.

Tham, X. C., Xie, H., Chng, C. M. L., Seah, X. Y., Lopez, V., & Klainin-Yobas, P. (2018). Exploring predictors of medication adherence among inpatients with schizophrenia in Singapore's mental health settings: A non-experimental study. Archives of Psychiatric Nursing, 32(4), 536-548.

Üçok, A., & Kara, İ. A. (2020). Relapse rates following antipsychotic discontinuation in the maintenance phase after first-episode of schizophrenia: Results of a long-term follow-up study. Schizophrenia Research, 225: 31-38

Videbeck, S.L (2018). Buku Ajar Keperawatan Jiwa. EGC.

WHO. (2003). Adherence to Long-term Therapies, Evidence for Action. Genewa.

World Health Organization. (2022). Schizophrenia. retrieved from https://www.who.int/news-room/fact-sheets/detail/schizophrenia?gclid=CjwKCAiA4smsBhAEEiwAO6DEjVa6LENzg2_pKwIQm1vk36aAtSJQWtlpgd69LcCWPRfdLFlTm3K2hRoC_UMQAvD_BwE

Xiao, J., Mi, W., Li, L., Shi, Y., & Zhang, H. (2015). High relapse rate and poor medication adherence in the Chinese population with schizophrenia: Results from an observational survey in the People’s Republic of China. Neuropsychiatric Disease and Treatment, 11, 1161-1167.

Yu, W., Tong, J., Sun, X., Chen, F., Zhang, J., Pei, Y., Zhang, T., Zhang, J., & Zhu, B. (2021). Analysis of Medication Adherence and Its Influencing Factors in Patients with Schizophrenia in the Chinese Institutional Environment. International journal of environmental research and public health, 18(9), 4746.

Downloads

Published

01/03/2024

How to Cite

Wardani, I. Y., Hamid, A. Y. S. ., & Keliat, B. A. (2024). Faktor-faktor yang Mempengaruhi Ketaatan Terapi pada Orang dengan Skizofrenia: Sebuah Systematic Review. Jurnal Keperawatan, 16(3), 1109–1118. https://doi.org/10.32583/keperawatan.v16i3.2039